Edition:
United Kingdom

Anavex Life Sciences Corp (AVXL.OQ)

AVXL.OQ on NASDAQ Stock Exchange Capital Market

3.15USD
15 Dec 2017
Change (% chg)

$-0.06 (-1.87%)
Prev Close
$3.21
Open
$3.22
Day's High
$3.23
Day's Low
$3.06
Volume
201,020
Avg. Vol
58,035
52-wk High
$6.63
52-wk Low
$3.03

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.10 September 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 2 0.00 0.00 0.00 --
Year Ending Sep-17 2 0.00 0.00 0.00 --
Year Ending Sep-18 1 0.00 0.00 0.00 0.00
Year Ending Sep-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-17 2 -0.10 -0.10 -0.10 --
Year Ending Sep-17 2 -0.37 -0.36 -0.38 --
Year Ending Sep-18 1 -0.35 -0.35 -0.35 -0.69
Year Ending Sep-19 1 -0.48 -0.48 -0.48 -0.70

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-16 0.00 0.00 0.00 0.00
Quarter Ending Mar-16 0.00 0.00 0.00 0.00
Quarter Ending Dec-15 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 0.00 -- -- -- --
Year Ending Sep-17 0.00 -- -- -- --
Year Ending Sep-18 0.00 0.00 0.00 -- 0.00
Year Ending Sep-19 0.00 0.00 0.00 -- 0.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-17 -- -- -- --
Year Ending Sep-17 -- -- -- --
Year Ending Sep-18 0 0 0 0
Year Ending Sep-19 0 0 0 0
Earnings